Journal of Hypertension: Open Access

Department of Biomedical Sciences, Alagappa University, Karaikudi, Tamil Nadu, India

Publications

• Review   
  Use of Lercanidipine and Enalapril in Combination Therapy for the Treatment of Hypertensive Patient
  Author(s): Md Amjad Noor* and Saleem Ahmad
  
  Due to its increased risk of heart failure, myocardial infarction, and stroke, hypertension is a significant risk factor for premature death. Antihypertensive medications can lower cardiovascular (CV) morbidity and death. To achieve blood pressure (BP) goals, the majority of hypertensive individuals require more than one antihypertensive medication. Only 20% to 40% of people respond well to monotherapy when trying to lower their blood pressure. The pathophysiology of hypertension is mediated by a number of factors, such as elevated peripheral vascular resistance, elevated cardiac effort, and hypervolemia. Multiple mechanisms can be targeted for increased BP reduction. Because the underlying mechanism causing the BP increase is either different or was previously treated with the lower dose, increasing the dose of a single medication frequently does not have the .. Read More»
  DOI: 10.37421/2167-1095.22.11.366

  Abstract HTML PDF